Efficacy of pazopanib in progressive, radioiodine-refractory, metastatic differentiated thyroid cancers: results of a phase 2 consortium study.
Lancet Oncol
; 11(10): 962-72, 2010 Oct.
Article
in En
| MEDLINE
| ID: mdl-20851682
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pyrimidines
/
Sulfonamides
/
Thyroid Neoplasms
/
Cell Differentiation
/
Radiopharmaceuticals
/
Protein Kinase Inhibitors
/
Iodine Radioisotopes
/
Antineoplastic Agents
Type of study:
Clinical_trials
/
Diagnostic_studies
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
America do norte
Language:
En
Journal:
Lancet Oncol
Journal subject:
NEOPLASIAS
Year:
2010
Type:
Article
Affiliation country:
United States